Imidazole compounds that modulate Hsp90 activity

Details for Australian Patent Application No. 2006279887 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Du, Zhenjian; Foley, Kevin; Ying, Weiwen

Agent Davies Collison Cave

Pub. Number AU-B-2006279887

PCT Pub. Number WO2007/021877

Priority 60/709,228 18.08.05 US

Filing date 10 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 16 June 2011

International Classifications

C07D 233/70 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4168 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 233/84 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/88 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/021877 Priority application(s): WO2007/021877

16 June 2011 Application Accepted

  Published as AU-B-2006279887

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279890-Continuous chamber mass confinement cells and methods of use thereof

2006279880-Tool-free adjustable clean-out assembly for a pump